Table 1 (abstract A75). See text for description
From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
Patient's characteristics | Mean ± SD, Frequency (%) |
|---|---|
Age (y) | 52.0± 10.7 |
BMI (Kg/m2) | 25.3± 6.6 |
Gender | F: 19/21 (90.5%) |
M: 2/21 (9.5%) | |
Acupuncture naive | 14/21 (66.7.%) |
Primary FM | 14/21 (66.7%) |
FM and autoimmune disease | 7/21 (33.3%) |
Education | Primary and lower secondary (age 5-13 ys): 5/21 (23.8%) |
Upper secondary (age 14-18 ys): 11/21 (52.4%) | |
Degree or more(>18ys): 5/21 (23.8%) | |
Pain therapy | No drugs: 2/21 (9.5%) |
1 drug: 10/21 (47.6%) | |
2 drugs: 5/21 (23.8%) | |
3 or more drugs: 4/21 (19.1%) | |
Muscle relaxants: 6/21 (28.6%) | |
Antidepressants: 7/21 (33.3%) | |
Antiepileptics: 5/21 (23.8%) | |
Paracetamol: 2/21 (9.5%) | |
Cox-2 inhibitors: 1/21 (4.8%) | |
Opioids: 10/21 (47.6%) | |
 Tapentadol: 5/21 (%) | |
 Buprenorphine transdermal patch: 5/21 (%) | |
Benzodiazepines: 2/21 (9.5%) | |
Cannabis: 1/21 (4.8%) | |
Rescue medications | No rescue meds: 10/21 (47.6%) |
Paracetamol: 3/21 (14.3%) | |
Other drug: 10/21 (47.6%) | |
WPI+SS (T0) | 20.3± 5.3 |
FIQR (T0) | 61.6±22.6 |